As of January 22, 2025, Greenwich LifeSciences (GLSI) has a market cap of $0.17 billion USD. According to our data, Greenwich LifeSciences is ranked No.7274 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.17 B |
13.18%
|
Dec 31, 2024 | $0.15 B |
6.75%
|
Dec 29, 2023 | $0.14 B |
-30.79%
|
Dec 30, 2022 | $0.20 B |
-37.53%
|
Dec 31, 2021 | $0.32 B |
-33.29%
|
Dec 31, 2020 | $0.48 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sutro Biopharma
STRO
|
$0.16 B |
-0.000 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Genmab
GMAB
|
$13.32 B |
0.000 M
|
Denmark
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Market Cap | = | GLSI Stock Price | * | GLSI Shares Outstanding |
= | $12.71 | * | 13.14 M | |
= | $0.17 B |